James N. Topper, Director at NewAmsterdam Pharma Co N.V. (NAMS), bought 8,010 shares at $21.02 ($168K) on 2025-03-04, disclosed to the SEC on 2025-03-06.
Open-market purchase of $168k NAMS by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.02 | 4,005 | $84K | 50.0% |
| 2 | $21.02 | 4,005 | $84K | 50.0% |
| Total | $21.02 avg | 8,010 | $168K | 100% |
| Filing → |
| NAMS | BUY | 2025-08-13 | $11K | — | Filing → |
| NAMS | BUY | 2025-06-26 | $69K | — | Filing → |
| NAMS | BUY | 2025-06-18 | $167K | — | Filing → |